Human macrophage migration inhibitory factor (MIF): A proven immunomodulatory cytokine?

Access to files

Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:

Abstract

Macrophage migration inhibitory factor (MIF) is a pro-inflammatory mediator with the ability to induce various immunomodulatory responses and override glucocorticoid-driven immunosuppression. Some of these functions have been linked to the unusual enzymatic properties of the protein, namely tautomerase and oxidoreductase activities. However, there are conflicting reports regarding the functional role of these enzymatic properties in normal physiological homeostasis and disease progression. Therefore, we have produced a highly pure, virtually endotoxin-free recombinant MIF preparation and fully characterized this using a variety of biochemical and biophysical approaches. The recombinant protein, with demonstrable enzymatic activity, was then used to systematically examine the biological activity of MIF. Surprisingly, treatment with MIF alone failed to induce cytokine expression, with the exception of IL-8. However, co-treatment of lipopolysaccharide (LPS) in conjunction with MIF produced synergistic secretion of tumor necrosis factor-alpha, interleukin (IL)-1, and IL-8 compared with LPS alone. The potentiating effect of MIF was seen at physiologically relevant concentrations. These data suggest that MIF has no conventional cytokine activity but, rather, acts to modulate and amplify the response to LPS.

Keyword(s)

Animals; Cell Line; Drug Synergism; Humans; Rats; biosynthesis: Cytokines; biosynthesis: Recombinant Proteins; chemistry: Inflammation Mediators; cytology: Granulocytes; cytology: Leukocytes, Mononuclear; genetics: Macrophage Migration-Inhibitory Factors; immunology: Cell Movement; immunology: Cell Survival; pharmacology: Lipopolysaccharides

Bibliographic metadata

Institutional metadata

Record metadata